N. Sulli

发表

The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial

B. Olsen, T. Battelino, I. Conget, 2012, Diabetologia.

Benefits of a bolus calculator in pre‐ and postprandial glycaemic control and meal flexibility of paediatric patients using continuous subcutaneous insulin infusion (CSII)

B Shashaj, E Busetto, N Sulli, 2008, Diabetic medicine : a journal of the British Diabetic Association.

Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin-dependent diabetes (the IMDIAB IV study)

A. Romiti, A. Signore, P. Pozzilli, 1997, European journal of endocrinology.

MODY 2 presenting as neonatal hyperglycaemia: a need to reshape the definition of “neonatal diabetes”?

A. Franzese, D. Iafusco, F. Prisco, 2000, Diabetologia.

Continuous Subcutaneous Insulin Infusion in Children and Adolescents with Diabetes Mellitus: Decreased HbA1c with Low Risk of Hypoglycemia

N. Sulli, B. Shashaj, 2003, Journal of pediatric endocrinology & metabolism : JPEM.

A multi‐centre randomized trial of two different doses of nicotinamide in patients with recent‐onset Type 1 diabetes (the IMDIAB VI)

G. Ghirlanda, A. Signore, P. Pozzilli, 1999, Diabetes/metabolism research and reviews.

Interaction of HIV‐1 with susceptible lymphoblastoid cells 1H NMR studies

V. Viti, L. Guidoni, A. Rosi, 1991, FEBS letters.

The role of socio‐economic and clinical factors on HbA1c in children and adolescents with type 1 diabetes: an Italian multicentre survey

A. Salvatoni, I. Rabbone, R. Paleari, 2017, Pediatric diabetes.

Cytogenetic, Molecular, Immunologic, and Ultrastructural Study on an Established Cell Line of a Stage III Neuroblastoma

C. Dominici, G. D’Orazi, A. Modesti, 1988 .

Variable number of tandem repeats in zygosity diagnosis in twins.

G. del Porto, N. Sulli, S. Costanzi Porrini, 1990, Acta geneticae medicae et gemellologiae.

Long‐term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4‐year follow‐up

N. Sulli, B. Shashaj, 2006, Diabetic medicine : a journal of the British Diabetic Association.

A male patient with 48,XXYY syndrome: importance of distinction from Klinefelter's syndrome

P. Grammatico, U. Bottoni, N. Sulli, 1990, Clinical genetics.

Difference in insulin usage patterns with pubertal development in children with type 1 diabetes during transition from multiple daily injections to continuous subcutaneous insulin infusion (CSII) and through the CSII treatment.

B Shashaj, N Sulli, N. Sulli, 2009, Diabetes technology & therapeutics.

High prevalence of glucokinase mutations in Italian children with MODY. Influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI

R. Lorini, F. Cerutti, A. Caumo, 2001, Diabetologia.

GAD and IA-2 autoantibody detection in type 1 diabetic patient saliva.

C. Tiberti, A. Verrienti, F. Dotta, 2009, Clinical immunology.

Health-related quality of life and treatment preferences in adolescents with type 1 diabetes. The VIPKIDS study

A. Salvatoni, A. Franzese, I. Rabbone, 2014, Acta Diabetologica.

Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study

B. Olsen, T. Battelino, I. Conget, 2014, Acta Diabetologica.

Use of continuous subcutaneous insulin infusion in patients with cystic fibrosis related diabetes: three case reports.

N. Sulli, S. Bertasi, B. Shashaj, 2007, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Case studies Use of continuous subcutaneous insulin infusion in patients with cystic fibrosis related diabetes: Three case reports

N. Sulli, S. Bertasi, B. Shashaj, 2007 .